Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Cash Flow Quality Index
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Cash Flow Quality Index of 1.48x as of December 2024. Operating cash flow of CN¥116.38 Million exceeds net income of CN¥78.85 Million, indicating high earnings quality where cash backs reported profits. Explore Medprin Regenerative Medical Technologie cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Medprin Regenerative Medical Technologies Co. Ltd. Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Medprin Regenerative Medical Technologies Co. Ltd. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Medprin Regenerative Medical Technologie generate cash.
Annual Cash Flow Quality Index for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year earnings quality comparison for Medprin Regenerative Medical Technologies Co. Ltd..
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.48x | CN¥116.38 Million | CN¥78.85 Million | ▼ -44.0% |
| 2023 | 2.63x | CN¥107.69 Million | CN¥40.88 Million | ▲ +95.7% |
| 2022 | 1.35x | CN¥48.31 Million | CN¥35.89 Million | ▼ -9.5% |
| 2021 | 1.49x | CN¥66.51 Million | CN¥44.73 Million | ▲ +62.1% |
| 2020 | 0.92x | CN¥33.91 Million | CN¥36.97 Million | ▼ -18.8% |
| 2019 | 1.13x | CN¥31.27 Million | CN¥27.68 Million | — |